Aptocrom앱토크롬
109960 · KOSDAQ · ₩109960 · 앱토크롬
- Market cap
- ₩26B
- Enterprise value
- ₩23B
- P/E
- 0.7×
- P/B
- 0.1×
- Dividend yield
- 0.0%
- ROE
- 10.6%
- Net margin
- 356.7%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−71.0% from the high
₩1,430Today: ₩1,726 – ₩1,755₩6,015
Returns
- 1W−6.8%
- 1M−6.0%
- 3M+9.4%
- 6M−44.1%
- YTD−63.8%
- 1Y−70.4%
- Volume today
- 2,871
- 1.7× the 20-day average
- Traded today
- ₩5M
- Listed shares
- 15,132,233
- EPS (12 months)
- ₩2,541
- Earnings yield 145.6%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 50 of 100 (50 is a normal day for this stock).
- MomentumWeak-5.9% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Aptocrom stock overview
Aptocrom (앱토크롬, KRX: 109960) is listed on KOSDAQ, in the Retail & Trade sector. The company distributes and sells pharmaceuticals, including external-use, digestive-tract, tonic and antibiotic products, and leases out its owned real estate and equipment. Its shares closed at ₩1,745 on Oct 28, 2026, up 0.11% on the day, giving it a market value of ₩26B.
Key facts
- Market cap
- ₩26B
- Sector
- Retail & Trade
- Latest price change
- +0.11%
- As of
- Oct 28, 2026
- Main business
- The company distributes and sells pharmaceuticals, including external-use, digestive-tract, tonic and antibiotic products, and leases out its owned real estate and equipment.
Quick answers about Aptocrom
- What does Aptocrom do?
- The company distributes and sells pharmaceuticals, including external-use, digestive-tract, tonic and antibiotic products, and leases out its owned real estate and equipment. Its subsidiary Aprogen I&C designs, manufactures, builds and installs industrial insulation, including nuclear-plant special insulation and Foamglas insulation, while other subsidiaries develop and supply software. Its pharmaceutical distribution business began in 2017 and it sells to wholesalers, with insulation customers including nuclear and petrochemical plant contractors.
- What is the market cap of Aptocrom?
- The market capitalisation of Aptocrom was ₩26B at the close on Oct 28, 2026.
- Who are the largest shareholders of Aptocrom?
- According to the latest official filings, the largest reported holders are Aprogen (85.77%, as of May 15, 2026); Forte New Technology Investment Partnership No. 240 (27.05%, as of May 15, 2026); Jibase (0.00%, as of Jun 5, 2026).
- When is the next earnings report from Aptocrom?
- Korean companies rarely announce results dates in advance. Based on when Aptocrom filed the same report in past years, its next 3q results is expected around Nov 13, 2026.
Company profile
The company distributes and sells pharmaceuticals, including external-use, digestive-tract, tonic and antibiotic products, and leases out its owned real estate and equipment. Its subsidiary Aprogen I&C designs, manufactures, builds and installs industrial insulation, including nuclear-plant special insulation and Foamglas insulation, while other subsidiaries develop and supply software. Its pharmaceutical distribution business began in 2017 and it sells to wholesalers, with insulation customers including nuclear and petrochemical plant contractors.
Written by AI from the company's latest annual report.
- Korean name
- 앱토크롬
- Sector
- Retail & Trade
- Themes
- —
- CEO
- 김정출
- Founded
- Feb 1998
- Listed
- Nov 2009
- Listed shares
- 15,132,233
- Fiscal year ends
- Month 12
- Website
- www.aprogen-hng.com
Similar companies
- Samsung C&T028260 · ₩53T₩324,500+7.81%
- POSCO International047050 · ₩8.8T₩49,750−0.20%
- ISC095340 · ₩3.5T₩165,900+9.65%
- Youngone111770 · ₩3T₩67,700−0.59%
- Dong SUH Companies026960 · ₩2.7T₩27,400−0.36%
- Shinsegae004170 · ₩2.4T₩257,500+5.10%
- Lotte Shopping023530 · ₩2.4T₩83,700+2.95%
- SK Gas018670 · ₩2.3T₩250,500+0.60%
Recent filings
See all- Half-year report (Jun 2026)Aug 13, 2026
- Decision to Acquire Equity-Linked BondsAug 10, 2026
- [Amended Filing] Decision to Acquire Equity-Linked BondsJun 29, 2026
- Amended: Major management matter relevant to investorsJun 26, 2026
- [Corrected Filing] Major Matters Report (Decision on Transfer of Equity-Related Bonds)Jun 26, 2026
Titles in Korean until English translations are added.
Also known as: Aptocrom / 앱토크롬 / 109960 / KRX:109960
Source: KRX statistical information